Pharmaceuticals: FDA Approved Warning Labels and Pre-emption


Event Details


The Food and Drug Administration approves the labels that contain the dangers of side effects and other contraindications for prescription drugs. Nevertheless, plaintiffs have successfully brought state-law based claims premised on the theory that these labels inadequately warned of some dangers of the drug.  The below panel addressed whether and/or under what circumstances such state-law claims should be pre-empted by federal law.

This Congressional Civil Justice Academy briefing featured:

Max Kennerly
Of Counsel, Tor Hoerman Law, LLC

Ana C. Reyes
Partner, Williams & Connolly

Moderator: Dennis M. Black
Acting Director of Education, Law & Economics Center

For more information, contact:
Keith J. W. Fierro
Program Assistant, CCJA
703.993.9964
kfierro@gmu.edu